11/13/2003

The Bristol-Myers Squibb experimental medication works better to reduce joint pain in rheumatoid arthritis patients than conventional treatments, a study says. Researchers hope this drug, used in combination with other treatments, may achieve better results with fewer side effects.

Related Summaries